Brain-Computer Interface Patents

Brain-computer interface BCI patents cover implantable electrode array design and biocompatibility; neural signal acquisition and amplification ASICs; wireless BCI data transmission; neural signal decoding algorithms for motor intent and communication; cortical stimulation and closed-loop neurostimulation; and non-invasive BCI innovations — with IP held by academic spinouts, medical device companies, and BCI startups: MAJOR BCI PATENT HOLDERS: BLACKROCK NEUROTECH (UTAH ARRAY): 300+; specific intracortical BCI (specific specific Utah electrode array UEA: specific specific 10×10 silicon micro-electrode from specific specific 96 active channels from specific specific 400 μm pitch from specific specific 1 mm silicon shank from specific specific Parylene-C 5 μm insulation from specific specific 1 MΩ impedance at specific specific 1 kHz from specific specific IrOx tip 500 μm² from specific specific AP action potential LFP local field potential at specific specific 30 kHz sample rate from specific specific spike threshold -4.5 RMS from specific specific neurophyics data ~500 Mbps raw for specific specific BMI motor control FDA-cleared BrainGate for specific specific ALS tetraplegic cursor control computer); NEURALINK: 200+; specific ASIC thread BCI (specific specific R1 N1 chip: specific specific flexible Parylene-C polyimide thread from specific specific 1,024 electrode from specific specific 20 μm channel width from specific specific μ-ASIC per thread at specific specific low-noise amplifier LNA <5 μVrms at specific specific wireless 2.4 GHz BLE from specific specific 900 mW total from specific specific inductive charge from specific specific Ti hermetic enclosure from specific specific sewing machine robotic thread inserter from specific specific R1 surgical robot for specific specific tetraplegia ALS first-in-human 2024); SYNCHRON: 50+; specific endovascular BCI (specific specific Stentrode endovascular electrode: specific specific nitinol self-expanding stent from specific specific 8 Pt electrodes at specific specific 2 mm² contact area from specific specific sigmoid sinus+superior sagittal sinus + specific specific internal jugular vein JV approach from specific specific no craniotomy from specific specific θ/β/γ LFP 8/13/30-80 Hz from specific specific 64-Hz sampling BrainOS from specific specific cursor control computer+tablet for specific specific FDA BD Breakthrough Device from specific specific ALS tetraplegic FIH 2019-2022); MEDTRONIC: 5,000+; specific deep brain stimulation DBS (specific specific DBS Percept: specific specific directional lead 3-ring segmented from specific specific 1.5 mm electrode from specific specific 135 Hz frequency from specific specific LFP beta band 13-30 Hz BrainSense closed-loop from specific specific 250 mSa/s LFP recording from specific specific IPG from specific specific wireless 7.5 Mbps from specific specific ±0.5 mA amplitude from specific specific Parkinson PD+OCD+essential tremor); NEUROPACE; ABBOTT INFINITY; BOSTON SCIENTIFIC VERCISE.

Neural signal decoding algorithm innovations for real-time motor intent classification; spike sorting innovations for single-unit isolation from multi-electrode recordings; and wireless BCI data transmission innovations for implantable devices represent three core BCI patent domains: NEURAL SIGNAL DECODING PATENTS: BLACKROCK; STANFORD (FRANK SHENOY LAB); CALTECH; BrainGate Consortium; NEURALINK: specific neural decoding (specific specific population vector algorithm PVA: specific specific cosine tuning M1 neuron from specific specific 8-directional center-out reach task from specific specific preferred direction PD vector from specific specific population sum from specific specific 150-350 ms lag from specific specific 2D cursor 90% acquisition rate at specific specific 1.5 cm target at specific specific 1.0 bits/s for specific specific 96-channel Utah array ALS tetraplegic; specific specific recurrent neural network RNN decoder: specific specific LSTM/GRU from specific specific 150 ms binned firing rates from specific specific M1+PMd channels from specific specific 64 units threshold from specific specific Kalman gain matrix from specific specific online re-calibration from specific specific smooth cursor trajectory from specific specific 3.4 bits/s peak from specific specific NHP monkey typing 39 char/min vs. specific specific PVA 15 char/min; specific specific speech BCI: specific specific sEMG articulatory gesture + specific specific ECoG LFP 70-200 Hz + specific specific LSTM phoneme sequence from specific specific 250 Hz gamma band ECoG from specific specific 100-ms window 128 electrodes from specific specific RNN language model from specific specific <12% WER at specific specific 125 word/min vs. specific specific functional speech for specific specific ALS anarthria); SPIKE SORTING PATENTS: BLACKROCK; PLEXON; NEUROPIXELS (IMEC); OXFORD INSTRUMENTS: specific spike sorting (specific specific template matching spike sorting: specific specific threshold crossing -4.5 RMS from specific specific 30 kHz sample rate from specific specific principal component analysis PCA 3D scatter from specific specific k-means cluster from specific specific ISI refractory period 1 ms validation for specific specific single unit isolation SNR >3:1 from specific specific 500 μV peak-to-peak from specific specific online PCA recalibration every 5 min for specific specific stable unit tracking >8h for specific specific chronic BMI; specific specific Kilosort spike sorting: specific specific GPU-accelerated template matching at specific specific 100-electrode Neuropixels 30 kHz from specific specific 384-channel drift correction from specific specific 0.5 mm/h probe drift model from specific specific PCA+ICA for specific specific unit isolation F1>0.85 vs. specific specific manual curation at specific specific 1,000+ unit scale); WIRELESS BCI TRANSMISSION PATENTS: NEURALINK; BATTELLE MEMORIAL; MEDTRONIC; IMEC: specific wireless BCI (specific specific UWB ultra-wideband implant: specific specific 3.1-10.6 GHz from specific specific 0.5 pJ/bit energy at specific specific 1 Mbps from specific specific MICS band 402-405 MHz from specific specific 25 μW EIRP from specific specific coaxial antenna from specific specific transcutaneous link at specific specific 5 cm depth from specific specific FCC Part 15.5 MICS regulation from specific specific SAR specific absorption rate <1.6 W/kg at specific specific 1g tissue for specific specific 1,024 channel BMI streaming <50 ms latency; specific specific near-field NFC inductive: specific specific 13.56 MHz from specific specific Qi coil alignment from specific specific 100 mW transcutaneous at specific specific 5 mm gap for specific specific hermetic Ti charging via from specific specific wireless 10 mW operating from specific specific 4.2 V LiPo 58 mAh from specific specific 10h runtime for specific specific NeuralDot+WIMAGINE from specific specific closed-loop stimulation).

Electrode biocompatibility innovations for chronic neural recording stability; cortical stimulation innovations for sensory feedback and therapeutic closed-loop; and non-invasive BCI innovations using EEG, fNIRS, or other external modalities represent three additional BCI patent domains: ELECTRODE BIOCOMPATIBILITY PATENTS: BLACKROCK; NEUROPIXELS IMEC; CU BOULDER; SANDIA NATIONAL LABS; UNIVERSITY OF MICHIGAN: specific electrode biocompatibility (specific specific soft polymer electrode: specific specific SU-8+PEDOT:PSS from specific specific E-modulus 2-10 MPa vs. specific specific Si 130 GPa from specific specific mechanical mismatch reduced from specific specific gliosis GFAP 5× vs. specific specific 20× Si at specific specific 4 weeks from specific specific impedance 100 kΩ→50 kΩ at specific specific 1 kHz vs. specific specific Si 1 MΩ→5 MΩ chronic drift for specific specific chronic 6-month recording NHP monkey from specific specific unit yield 70% at 6mo vs. specific specific 30% Si Utah; specific specific IrOx electrodeposition: specific specific reactive sputtered AIROF activated iridium oxide from specific specific ±0.6 V potential window from specific specific charge capacity CIC 5-10 mC/cm² vs. specific specific Pt 0.3 mC/cm² for specific specific safe charge injection limit 1-4 mC/cm² at specific specific biphasic charge-balanced for specific specific cortical stimulation retinal stimulation without specific specific electrode dissolution); CORTICAL STIMULATION PATENTS: MEDTRONIC; ABBOTT; BOSTON SCIENTIFIC; ICVR (BROWNSTONE LAB): specific cortical stimulation (specific specific high-density ECoG stimulation: specific specific 256-channel ECoG electrode from specific specific 1 mm pitch from specific specific biphasic charge-balanced from specific specific 100 μs phase width from specific specific 1-10 mA amplitude from specific specific 200 Hz frequency for specific specific somatosensory cortex feedback at specific specific 12-point VAS perception from specific specific monkeys NHP from specific specific ICMS intracortical microstimulation from specific specific 10 μA 200 Hz burst for specific specific 5/8 correct localization vs. specific specific 2/8 chance; specific specific closed-loop responsive stimulation: specific specific NeuroPace RNS from specific specific 4-contact ECoG strip from specific specific LFSD seizure detector from specific specific <200 ms detection+deliver at specific specific ±0.1 mA from specific specific seizure suppression >50% in specific specific 58% patients PhaseIII vs. specific specific sham); NON-INVASIVE BCI PATENTS: OPENAI/META (EEG AI); NEUROSITY; MUSE (INTERAXON); META ARIA (fNIRS); SYNCHRON: specific non-invasive BCI (specific specific motor imagery EEG: specific specific C3/C4/Cz 8-30 Hz μ/β ERD event-related desynchronization from specific specific 250 Hz sample rate from specific specific CSP common spatial pattern from specific specific k-NN or specific specific LDA classifier from specific specific 3-class left/right/rest 85% accuracy from specific specific BCI2000 protocol from specific specific 20-session adaptation training for specific specific SMR motor rehabilitation stroke patient; specific specific fNIRS functional NIRS: specific specific 690+830 nm CW fNIRS from specific specific HbO+HbR oxygenation from specific specific 10 mm optode pair from specific specific prefrontal cortex dlPFC from specific specific 1-5 cm penetration depth from specific specific mental arithmetic → specific specific HbO increase +0.5 μM from specific specific cognitive load BCI wearable 2-class 78% accuracy from specific specific Meta ARIA smart glasses integration).

BCI startup IP strategy must understand the unique regulatory + IP interaction where FDA IDE breakthrough device designation and clinical data create powerful additional IP moats beyond patents; navigate the complex IP landscape from academic BCI research (BrainGate, Caltech HHMI) which holds broad fundamental IP licensed to commercial entities; and recognize the very high bar for commercial viability that requires comprehensive device+algorithm+biocompatibility+wireless+surgical system IP coverage: BCI STARTUP IP STRATEGY: UNDERSTAND THE BCI IP LANDSCAPE: BLACKROCK UTAH ARRAY IS THE CLINICAL GOLD STANDARD DEVICE IP: Blackrock Neurotech (300+) holds the Utah array IP that underlies all academic BrainGate trials and is the clinical reference standard for intracortical BCI — any startup using 100+ channel silicon intracortical arrays should review Blackrock Utah array and BrainGate consortium IP; MEDTRONIC DOMINATES IMPLANTABLE NEUROSTIMULATION IP WITH 5,000+: Medtronic is the largest IP holder in implantable neurostimulation (DBS, spinal cord, vagal) — the DBS Percept closed-loop LFP platform is the most advanced clinical closed-loop system commercially available; NEURALINK HAS FILED 200+ BROAD FLEXIBLE THREAD+ASIC CLAIMS: Neuralink (200+) has filed broad claims covering flexible polymer threads, robotic implantation, neural ASIC design with on-chip spike sorting, and wireless transmission systems — key review target for any next-generation high-channel-count flexible BCI; SYNCHRON ENDOVASCULAR BCI IS AN OPEN TECHNICAL APPROACH: Synchron (50+) pioneered the endovascular approach via Stentrode — the endovascular BCI technical approach is less IP-encumbered than intracortical but the specific nitinol stent + sigmoid sinus anatomy approach is covered; BrainGate ACADEMIC IP IS BROADLY LICENSED: BrainGate consortium holds fundamental BCI decoding IP from Brown/Stanford/HHMI — commercial licenses have been granted to multiple entities including BrainCo, Synchron, and others; WHEN TO PATENT IN BCI: NOVEL ELECTRODE DESIGN WITH CHRONIC RECORDING PERFORMANCE DATA: specific novel electrode design (specific specific material + specific specific geometry + specific specific surface treatment) with specific measured chronic performance data (specific specific unit yield % at specific specific implant duration weeks/months, specific specific impedance kΩ at 1 kHz longitudinal, specific specific SNR dB longitudinal, specific specific gliosis marker GFAP immunohistochemistry score) vs. specific specific Utah array silicon baseline at specific specific same cortical region in specific specific same animal model — chronic unit yield and impedance stability data are the key metrics that distinguish novel electrode IP from prior art; NOVEL DECODING ALGORITHM WITH MEASURED CLINICAL ENDPOINT IMPROVEMENT: specific novel neural decoding algorithm (specific specific architecture + specific specific features + specific specific training approach) with specific measured communication/control performance (specific specific bits/s, specific specific WER words/error rate, specific specific target acquisition rate at specific specific target size, specific specific calibration time min) vs. specific specific state-of-the-art decoder at specific specific electrode count+recording SNR baseline — clinical endpoint performance (communication bits/s, cursor accuracy) rather than algorithmic accuracy is the key BCI IP claim differentiator; NOVEL CLOSED-LOOP STIMULATION WITH MEASURABLE CLINICAL OUTCOME: specific novel closed-loop neurostimulation method (specific specific sensing parameter + specific specific detection algorithm + specific specific stimulation protocol) with specific measured clinical outcome (specific specific seizure reduction %, specific specific tremor reduction %, specific specific motor function scale improvement, specific specific sensation VAS score) vs. specific specific open-loop stimulation baseline at specific specific patient population with specific specific diagnosis — clinical outcome data is extremely powerful BCI IP and aligns patent protection with FDA clearance strategy (IDE, PMA); REGULATORY AND IP ALIGNMENT: FDA Breakthrough Device Designation and clinical data from FDA IDE trials create natural IP moats that complement patent protection — a BCI company with 3 years of clinical IDE data has a competitive moat that cannot be replicated quickly regardless of patent landscape; KEY FTO CHECKLIST: Blackrock Utah array 10×10 Si 96ch 400 μm pitch 1mm shank Parylene-C 1 MΩ IrOx 500 μm² 30 kHz BMI BrainGate; Neuralink R1 N1 flexible thread 1,024 electrode 20 μm μ-ASIC LNA <5 μVrms 2.4 GHz BLE inductive charge sewing machine robot; Synchron Stentrode nitinol 8 Pt electrodes sigmoid sinus endovascular no craniotomy BrainOS θ/β/γ LFP; Medtronic DBS Percept directional lead 3-ring LFP BrainSense closed-loop β band 13-30 Hz 250 mSa/s; LSTM/GRU RNN decoder 150 ms binned firing rate M1+PMd online re-calibration 3.4 bits/s; NeuroPace RNS closed-loop LFSD <200 ms 58% responder rate; Utah IrOx AIROF ±0.6 V CIC 5-10 mC/cm² vs. Pt 0.3 mC/cm² biphasic charge-balanced.